Saudi Arabia Crispr And Cas Genes Market Size & Outlook
Saudi Arabia crispr and cas genes market, 2018-2030 (US$M)
Related Markets
Saudi Arabia crispr and cas genes market highlights
- The Saudi Arabia crispr and cas genes market generated a revenue of USD 27.9 million in 2024 and is expected to reach USD 63.1 million by 2030.
- The Saudi Arabia market is expected to grow at a CAGR of 14.9% from 2025 to 2030.
- In terms of segment, product was the largest revenue generating product & service in 2024.
- Service is the most lucrative product & service segment registering the fastest growth during the forecast period.
Crispr and cas genes market data book summary
| Market revenue in 2024 | USD 27.9 million |
| Market revenue in 2030 | USD 63.1 million |
| Growth rate | 14.9% (CAGR from 2025 to 2030) |
| Largest segment | Product |
| Fastest growing segment | Service |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Product, Service |
| Key market players worldwide | AstraZeneca PLC, Caribou Biosciences Inc Ordinary Shares, Cellectis SA, CRISPR Therapeutics AG, Editas Medicine Inc, Roche Holding AG, PerkinElmer, Genscript Biotech Corp Class H, Danaher Corp, Intellia Therapeutics Inc, Lonza Group Ltd, Merck KGaA, Takara Bio Inc, Thermo Fisher Scientific Inc, Cibus Inc Ordinary Shares - Class A, Beam Therapeutics Inc, Vertex Pharmaceuticals Inc, Addgene, EGenesis, Synthego, Mammoth Biosciences, Inscripta, PLANTEDIT, Hera Biotech, Origene Technologies, Recombinetics |
Other key industry trends
- In terms of revenue, Saudi Arabia accounted for 0.6% of the global crispr and cas genes market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia crispr and cas genes market is projected to lead the regional market in terms of revenue in 2030.
- Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 63.1 million by 2030.
Product was the largest segment with a revenue share of 86.74% in 2024. Horizon Databook has segmented the Saudi Arabia crispr and cas genes market based on product, service covering the revenue growth of each sub-segment from 2018 to 2030.
Extensive research studies involving genome editing techniques can help expand the usage rate of advanced CRISPR techniques in this country. In January 2020, researchers from the King Abdullah University of Science and Technology integrated Agrobacterium VirD2 release (Cas9-VirD2) and Cas9 endonuclease, which enabled efficient Homology-directed Repair (HDR).
The Cas9-VirD2 system was validated to develop herbicide-resistant rice plants, thus improving vital characteristics of crop s. Such research studies are anticipated to increase CRISPR utilization in agriculture in the country.
The advent of CRISPR has accelerated advancements in novel, efficient, and simplistic in vivo model systems in oncology. Researchers from King Abdul-Aziz University, as per a study published in December 2019, reviewed development and application of CRISPR techniques for cancer research & therapy.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
CRISPR And Cas Genes Market Scope
CRISPR And Cas Genes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Saudi Arabia crispr and cas genes market size, by product & service, 2018-2030 (US$M)
Saudi Arabia CRISPR And Cas Genes Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
